BDNF, along with its receptors, is implicated in the pathophysiology of neurodegenerative disorders such as Alzheimer's disease, amyotrophic lateral sclerosis, and Rett syndrome, positioning it as a potential therapeutic target [35, 36]. Here, BDNF is linked to early-onset autosomal dominant Alzheimer disease.